Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/02/2000 | WO2000031243A1 Novel serine protease bssp5 |
06/02/2000 | WO2000031187A1 Water soluble fluorescent dyes free of aggregation and serum binding and related products and methods |
06/02/2000 | WO2000031133A2 Potassium channel interactors and uses therefor |
06/02/2000 | WO2000031124A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
06/02/2000 | WO2000031122A1 Hydrophilic somatostatin analogs |
06/02/2000 | WO2000031115A1 Methods of identifying antigen gene sequences |
06/02/2000 | WO2000031108A1 Dna molecules encoding hg51, a g-protein-coupled receptor |
06/02/2000 | WO2000031101A1 Method for the electrochemical detection of nucleic acid oligomer hybrids |
06/02/2000 | WO2000030929A1 Device support for probes and instruments used in under-water measuring techniques |
06/02/2000 | WO2000030753A1 Purification method and apparatus |
06/02/2000 | WO2000030750A2 Method for operating a water softening ion exchanger system with regenerative unit by measuring in situ the water hardness by means of an ion-selective sensory mechanism and arrangement for carrying out such a method |
06/02/2000 | WO2000030698A1 Apparatus and method for control of tissue/implant interactions |
06/02/2000 | WO2000030667A2 Compositions and methods using lactadherin or variants thereof |
06/02/2000 | WO2000030662A1 Fabz |
06/02/2000 | WO2000030628A2 Method of inhibiting angiogenesis |
06/02/2000 | WO2000030590A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
06/02/2000 | WO2000030532A1 Generic integrated implantable potentiostat telemetry unit for electrochemical sensors |
06/02/2000 | WO2000030425A2 Method of using pon-1 to decrease atheroma formation |
06/02/2000 | WO2000016061A3 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates |
06/02/2000 | WO2000014545A9 Multihued labels |
06/02/2000 | WO2000014542A3 Diagnostic method for detecting disturbances of the pancreas |
06/02/2000 | WO2000014535A9 Interstitial fluid methods and devices for determination of an analyte in the body |
06/02/2000 | WO2000014283A3 Gene markers for chronic mucosal injury |
06/02/2000 | WO2000013703A9 Methods of treating hypertension and compositions for use therein |
06/02/2000 | WO2000013020A3 Cellular transport detection system |
06/02/2000 | WO2000013016A3 Method for preparing artificial receptors |
06/02/2000 | WO2000013010A3 Systems and methods for fenceline air monitoring of airborne hazardous materials |
06/02/2000 | WO2000012545A3 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6 |
06/02/2000 | WO2000011141A3 Trna binding domain |
06/02/2000 | WO1999067642A3 Method of detecting an antibody in a liquid sample |
06/02/2000 | WO1999064594A8 Genes and gene expression products that are differentially regulated in prostate cancer |
06/02/2000 | WO1999063095A9 Nucleic acid vaccines for prevention of flavivirus infection |
06/02/2000 | WO1999062942A3 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
06/02/2000 | WO1999061888A9 Microfabricated cell sorter |
06/02/2000 | CA2645717A1 Human orphan g protein-coupled receptors |
06/02/2000 | CA2354060A1 Apparatus and method for control of tissue/implant interactions |
06/02/2000 | CA2352606A1 Urotensins ii of mammals and their uses |
06/02/2000 | CA2352495A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
06/02/2000 | CA2352458A1 Compositions and methods using lactadherin or variants thereof |
06/02/2000 | CA2352456A1 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids |
06/02/2000 | CA2352083A1 Zace1: a human metalloenzyme |
06/02/2000 | CA2352042A1 Multiplex amplification of short tandem repeat loci |
06/02/2000 | CA2351944A1 Hydrophilic somatostatin analogs |
06/02/2000 | CA2351893A1 Peptides that modulate the interaction of b class ephrins and pdz domains |
06/02/2000 | CA2351885A1 Test kit and method of diagnosing severe acute pancreatitis |
06/02/2000 | CA2351880A1 Dna molecules encoding hg51, a g-protein-coupled receptor |
06/02/2000 | CA2351872A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption |
06/02/2000 | CA2351736A1 Methods of identifying antigen gene sequences |
06/02/2000 | CA2351734A1 Generic integrated implantable potentiostat telemetry unit for electrochemical sensors |
06/02/2000 | CA2351667A1 Method for modifying and identifying functional sites in proteins |
06/02/2000 | CA2351616A1 Purification method and apparatus |
06/02/2000 | CA2351567A1 Mutation of the parkin gene, compositions, methods and uses |
06/02/2000 | CA2351479A1 Electrically conductive electroactive functionalized conjugated polymers, and uses thereof |
06/02/2000 | CA2351419A1 Method and device for automated chromophore-assisted laser/light inactivation (cali) |
06/02/2000 | CA2351365A1 Potassium channel interactors and uses therefor |
06/02/2000 | CA2351361A1 Gtpase associated proteins |
06/02/2000 | CA2351166A1 Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide |
06/02/2000 | CA2351143A1 Method for identifying cytosine methylation patterns in genomic dna |
06/02/2000 | CA2351065A1 Method for screening cd14 agonist or antagonist |
06/02/2000 | CA2350756A1 Methods and apparatus for flow-through hybridization |
06/02/2000 | CA2350658A1 Diagnosis of demyelinating or spongiform disease |
06/02/2000 | CA2350608A1 Water soluble fluorescent dyes free of aggregation and serum binding and related products and methods |
06/02/2000 | CA2350599A1 Method of inhibiting angiogenesis |
06/02/2000 | CA2350405A1 Method of using pon-1 to decrease atheroma formation |
06/02/2000 | CA2349337A1 Prion protein standard and method of making same |
06/02/2000 | CA2349229A1 Prevention and treatment of amyloid-associated disorders |
06/02/2000 | CA2347700A1 Antibodies to peptides that target git receptors and related methods |
06/02/2000 | CA2345157A1 Method for electrochemically detecting nucleic acid oligomer hybrids |
06/02/2000 | CA2319187A1 Measurement of hydride using chemiluminescent acridinium compounds |
06/02/2000 | CA2318776A1 Monitoring patient compliance and bioavailability of drugs by deproteinizing body fluids |
05/31/2000 | EP1004881A1 System for the reduction of interferences in immunoassays |
05/31/2000 | EP1004880A2 Erythroblast diagnostic flow-cytometry method and reagents |
05/31/2000 | EP1004879A1 Method and equipment for testing the colour and reflectivity of high-visibility garments |
05/31/2000 | EP1004873A1 Method and apparatus for identifying the function of biological molecules |
05/31/2000 | EP1004872A1 System and method for sensing the quality of a medium |
05/31/2000 | EP1004869A1 Method and apparatus for handling samples |
05/31/2000 | EP1004674A1 Human adamts-1 protein, gene coding for the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein |
05/31/2000 | EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
05/31/2000 | EP1004664A1 Compositions and methods using lactadherin or variants thereof |
05/31/2000 | EP1004367A2 System for sorting plastic objects for recycling |
05/31/2000 | EP1004322A2 Technetium-99m labeled peptides for thrombus imaging |
05/31/2000 | EP1004106A1 Carbon monoxide and smoke detection apparatus |
05/31/2000 | EP1004056A1 Multi parameter scanner |
05/31/2000 | EP1004025A1 Multi-layer testing column |
05/31/2000 | EP1004024A1 Hydrophobic fluorescent polymer membrane for the detection of ammonia |
05/31/2000 | EP1004023A2 Rapid assay for simultaneous detection and differentiation of antibodies to hiv |
05/31/2000 | EP1004022A1 Methods and compositions for overcoming resistance to biologic and chemotherapy |
05/31/2000 | EP1004021A1 Determining the transforming capability of agents |
05/31/2000 | EP1004020A1 Aggregometer with disposable test cell |
05/31/2000 | EP1004015A1 Apparatus for performing assays at reaction sites |
05/31/2000 | EP1003932A1 Methods for modeling two-dimensional responses of cross-machine direction actuators in sheet-forming processes |
05/31/2000 | EP1003910A1 Multiple functionalities within an array element and uses thereof |
05/31/2000 | EP1003908A1 Nucleic acid archiving |
05/31/2000 | EP1003906A1 Fluorescent polymeric sensor for the detection of creatinine |
05/31/2000 | EP1003905A1 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures |
05/31/2000 | EP1003904A1 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds |
05/31/2000 | EP1003888A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
05/31/2000 | EP1003879A1 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
05/31/2000 | EP1003878A2 Hiv-1 group o antigens and uses thereof |
05/31/2000 | EP1003877A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |